WHO prequalifies first typhoid conjugate vaccine for young children
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
WHO announced it has prequalified the Typhoid Vi Capsular Polysaccharide Tetanus Toxoid Conjugate (Typbar TCV, Bharat Biotech;TCV) for routine use in children aged 6 months in typhoid-endemic countries.
Prequalification indicates it has met WHO standards for quality, safety, an...
You’ve reached the visitor articles limit
Free registrationreserved for healthcare professionals